Moderna secures up to $50 million to develop an Ebola vaccine.

BioNTech co-founders Dr. Ugur Sahin and Dr. Ozlem Tureci in its headquarters in Germany on Jan. 3.Photograph by Dina Litovsky—Redux for TIME “No!” The doctor snapped. “Look at me!” I had been staring ...

Researchers at the University of Kentucky are testing the effectiveness of a vaccine that may be able to treat pancreatic cancer. As one of 15 research institutions across the nation taking part in ...

Stockholm — The Nobel Prize in medicine has been awarded to Hungarian Katalin Karikó and Drew Weissman of the U.S. for discoveries that enabled the development of effective mRNA vaccines against COVID ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application ...

CINCINNATI, Ohio — A new artificial intelligence tool developed at the University of Cincinnati can accurately predict whether someone is willing to be vaccinated against COVID-19 with only a little ...

It was January 2020 when COVID-19 was first reported in the United States. Six months later, Julia Moore Vogel started feeling the symptoms. But they didn’t go away in a couple of weeks. Today, three ...